Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Clinical Platform Trial Investigating Multiple Therapeutic Options for the Treatment of Hospitalized Patients With Acute Respiratory Distress Syndrome (ARDS)

NCT06701682 is registered in ClinicalTrials.gov with PPD Development, LP as lead sponsor.

NCT NCT06701682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06701682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Clinical Platform Trial Investigating Multiple Therapeutic Options for the Treatment of Hospitalized Patients With Acute Respiratory Distress Syndrome (ARDS)
Lead sponsor
PPD Development, LP
Phase
Phase 2
Overall status
Recruiting
Start date
June 21, 2025
Completion date
September 30, 2028
Enrollment
200 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, acute respiratory distress syndrome (ards), ards, ards (acute respiratory distress syndrome)